CureVac sues Moderna over COVID-19 vaccine patent infringement
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui, April 27 — German biotechnology company CureVac filed a lawsuit against Moderna last Friday in a federal court in Delaware, accusing its COVID-19 vaccine Spikevax of infringing the company’s patents related to mRNA technology, and demanding compensation in the form of patent royalties based on Spikevax’s sales revenue. Moderna stated in a statement that it is aware of the litigation and will defend itself.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Crypto prices
MoreBitcoin
BTC
$84,127.87
+0.41%
Ethereum
ETH
$2,723.72
+1.00%
Tether USDt
USDT
$0.9999
+0.01%
BNB
BNB
$764.77
-0.33%
XRP
XRP
$1.55
+1.52%
USDC
USDC
$1
+0.01%
Solana
SOL
$121.1
+0.87%
TRON
TRX
$0.3349
+0.02%
Zcash
ZEC
$1,444.58
-9.14%
Hyperliquid
HYPE
$88.23
-1.46%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now